Translocator protein-mediated fast-onset antidepressant-like and memory-enhancing effects in chronically stressed mice

J Psychopharmacol. 2020 Apr;34(4):441-451. doi: 10.1177/0269881119896304. Epub 2020 Jan 8.

Abstract

Background: Fast-acting and cognitive-enhancing antidepressants are desperately needed. Activation of translocator protein (18 kDa, TSPO) is a novel strategy for developing potential antidepressants, but there are no data available on the onset time of TSPO ligands. This study aimed to investigate the fast-onset antidepressant actions of AC-5216, a selective TSPO ligand, in TSPO knock-out (KO) mice.

Methods: TSPO wild-type (WT) and KO mice were subjected to a six-week chronic unpredicted stress (CUS) paradigm. Then, the mice were treated with AC-5216 and tested with depressive and cognitive behaviours.

Results: A single dose of AC-5216 (0.3 mg/kg) exerted anxiolytic- and antidepressant-like actions in TSPO WT mice. Moreover, in chronically stressed WT mice, two to four days of AC-5216 treatment (0.3 mg/kg, once per day) produced fast-onset antidepressant-like effects in the novelty-suppressed feeding and sucrose preference tests, as well as memory-enhancing effects in the novel object recognition test. In addition, a rapid (with five days of treatment) restoration of serum corticosterone levels and prefrontal cortex (PFC) allopregnanolone levels was found. Further studies showed that in these stress-exposed WT mice, AC-5216 significantly increased the levels of mTOR signalling-related proteins (mBDNF, p-mTOR, PSD-95, synapsin-1, GluR1), as well as the total dendritic length and branching points of pyramidal neurons in the PFC.

Conclusions: These results suggest that TSPO mediates the fast-onset antidepressant-like and memory-enhancing effects of AC-5216, possibly through the rapid activation of mTOR signalling and restoration of dendritic complexity in the PFC.

Keywords: TSPO; allopregnanolone; dendritic complexity; depression; fast-onset antidepressant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Antidepressive Agents*
  • Behavior, Animal / drug effects
  • Chronic Disease
  • Corticosterone / blood
  • Dendrites / drug effects
  • Dendrites / ultrastructure
  • Memory / drug effects*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism
  • Pregnanolone / metabolism
  • Purines / pharmacology
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / ultrastructure
  • Receptors, GABA / drug effects
  • Receptors, GABA / genetics
  • Receptors, GABA / physiology*
  • Recognition, Psychology
  • Stress, Psychological / psychology*
  • TOR Serine-Threonine Kinases / drug effects

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Bzrp protein, mouse
  • N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide
  • Purines
  • Receptors, GABA
  • Pregnanolone
  • mTOR protein, mouse
  • TOR Serine-Threonine Kinases
  • Corticosterone